BioCentury
ARTICLE | Company News

FTA Bioscience, Pure Bioscience deal

August 9, 2010 7:00 AM UTC

Pure Bioscience granted FTA exclusive, worldwide rights to develop and commercialize a topical silver dihydrogen citrate (SDC)-based product for onychomycosis and tinea pedis (athlete's foot). The ele...